Investigation of the Safety and Effectiveness of a Trifocal IOL
Public ClinicalTrials.gov record NCT04176965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Investigation of the Safety and Effectiveness of FINEVISION HP Trifocal IOL
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a prospective, multicenter, randomized, double masked confirmatory trial comparing an investigational trifocal intraocular lens (IOL) and a commercially available monofocal IOL.
Study identification
- NCT ID
- NCT04176965
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 539 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 28, 2022 (Actual)
- Primary completion
- May 13, 2024 (Actual)
- Completion
- May 13, 2024 (Actual)
- Last update posted
- Jan 29, 2025
2022 – 2024
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mitchell C Shultz MD/Shultz Chang Vision | Northridge | California | 91325 | — |
| Coastal Vision Medical Group | Orange | California | 92868 | — |
| Arbor Centers for Eye Care | Orland Park | Illinois | 60467 | — |
| Michael Washburn Center for Ophthalmic Research | Indianapolis | Indiana | 46240 | — |
| Vance Thompson Vision, MN Site | Alexandria | Minnesota | 56308 | — |
| Chu Vision Institute | Bloomington | Minnesota | 55420 | — |
| Ophthalmology Consultants, Ltd | St Louis | Missouri | 63131 | — |
| Vance Thompson Vision, MT Site | Bozeman | Montana | 59718 | — |
| Vance Thompson Vision NE Site | Omaha | Nebraska | 68137 | — |
| Center For Sight | Las Vegas | Nevada | 89145 | — |
| Eye Associates & SurgiCenter | Vineland | New Jersey | 08361 | — |
| Vance Thompson Vision ND Site | West Fargo | North Dakota | 58078 | — |
| Cleveland Eye Clinic | Brecksville | Ohio | 44141 | — |
| Associates in Ophthalmology Ltd | West Mifflin | Pennsylvania | 15122 | — |
| Vance Thompson Vision. SD Site | Sioux Falls | South Dakota | 57108 | — |
| Key-Whitman Eye Center | Dallas | Texas | 75243 | — |
| Lehmann Eye Center | Nacogdoches | Texas | 75965 | — |
| Parkhurst Nuvision | San Antonio | Texas | 78229 | — |
| The Eye Institute of Utah | Salt Lake City | Utah | 84107 | — |
| Piedmont Eye Center | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04176965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04176965 live on ClinicalTrials.gov.